Skip to content

Pain

Pain Management

NHS England (2013 data) suggests that approximately 14 million people live with persistent or chronic pain in the UK. This affects their health, quality of life and ability to work. Napp have been committed to furthering the understanding and treatment of pain for over 35 years.

© 2024 NAPP PHARMACEUTICALS LIMITED. DOP: July 2024 UK-CORP-2200003 v10.0

Opioid Charter

For Mundipharma’s Charter on the responsible medical use of opioid analgesics in pain management click here.

Opioid Safety Statement

“Attention should be given as the use of opioids has a risk of addiction, misuse and abuse. Therefore, appropriate assessment and monitoring is a requirement at initiation, maintenance and tapering down of opioid therapy.”